- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03381495
The Association Between Epidural Labor Analgesia and Pregnancy Outcomes
July 11, 2018 updated by: Deng Dongrui
Labor analgesia can alleviate intrapartum pain, in the importance of the delivery is very obvious.But some researches think labor analgesia may affect the progress of labor, increase the cesarean section rate.This research adopts the epidural anesthesia to study labor analgesia effects on delivery outcomes and long-term emotional and psychological effects on the mothers.
Besides, we also want to study the effect of exercise during pregnancy on the mode of delivery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Recruiting
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
-
Principal Investigator:
- Haiyi Liu, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 50 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
healthy and full term pregnant women
Exclusion Criteria:
the pregnant women with complications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Epidural analgesia during labor
The epidural analgesia technique was used to maintain analgesia for parturients who request labor analgesia.First, we injected a test dose of 5ml 1% lidocaine .
If not adverse effects were observed 10 minutes after the test dose, the parturient then received a bolus injection of an initial dose of 8-10 ml mixed liquids of 0.075% ropivacaine and 0.2ug/ml sufentanil citrate.
We then connected the epidural catheter with a patient-controlled epidural analgesia (PCA) pump, which provided patients the same mixed solution at 8-10ml/h until the delivery of neonates.
|
In this research one group will receive epidural analgesia(Ropivacaine Hydrochloride, Sufentanil), data will be collected and analyzed between this group and non-epidural analgesia group.
|
|
NO_INTERVENTION: Non-epidural analgesia during labor
Women who refused epidural labor analgesia were included in the non-epidural analgesia group, and they don't receive epidural analgesia during labor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Labor duration
Time Frame: At the end of the delivery
|
Duration of three stages of labor.
|
At the end of the delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1 minute Apgar index
Time Frame: 1 minute after the infant is born
|
The index indicates the infant s' conditions, including heart rate, breathing, muscle tone, reflex response, color.
Each characteristic is given an individual score; two points for each of the five categories if all is completely well; then all scores are totaled.
The score is from 0 to 10.
|
1 minute after the infant is born
|
|
5 minute Apgar index
Time Frame: 5 minutes after the infant is born
|
The index indicates the infant s' conditions, including heart rate, breathing, muscle tone, reflex response, color.
Each characteristic is given an individual score; two points for each of the five categories if all is completely well; then all scores are totaled.
The score is from 0 to 10.
|
5 minutes after the infant is born
|
|
Visual Analogue Scores(VAS)
Time Frame: 5min before analgesia;5min,15min, 30min,60min after analgesia; at the time of latent phase, active phase, full dilation of the cervix, crowning of head, and laceration repair.
|
VAS is the most common pain scale for quantification.
The score is from 0 to 10.
The score is higher, the patient will be more painful.
That will indicate if the analgesia is effective.
|
5min before analgesia;5min,15min, 30min,60min after analgesia; at the time of latent phase, active phase, full dilation of the cervix, crowning of head, and laceration repair.
|
|
Modified Bromage scores
Time Frame: 5min before analgesia;5min,15min, 30min,60min after analgesia; at the time of latent phase, active phase, full dilation of the cervix, crowning of head, and laceration repair.
|
The modified Bromage score is the most frequently used measure of motor block.
The scores is from 0 to 3. In this scale, the intensity of motor block is assessed by the patient's ability to move their lower extremities (0: no motor paralysis; 1: inability to raise extended leg, but able to move knee and foot; 2: inability to raise extended leg and to move knee, but able to move foot; 3: inability to raise extended leg or to move knee and foot).
That will indicate if the analgesia block the patient motor too much.
|
5min before analgesia;5min,15min, 30min,60min after analgesia; at the time of latent phase, active phase, full dilation of the cervix, crowning of head, and laceration repair.
|
|
Postpartum depression
Time Frame: 3 days after delivery,6 weeks after delivery, 3 months after delivery, 6 months after delivery, 1 year after delivery.
|
Assess the risk of postpartum depression among all participants using EPDS,HAMA.
|
3 days after delivery,6 weeks after delivery, 3 months after delivery, 6 months after delivery, 1 year after delivery.
|
|
The mode of delivery
Time Frame: At the end of delivery
|
Including spontaneous vaginal delivery, vacuum- and forceps-assisted delivery, cesarean delivery.
|
At the end of delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 16, 2018
Primary Completion (ANTICIPATED)
September 1, 2018
Study Completion (ANTICIPATED)
December 31, 2019
Study Registration Dates
First Submitted
December 2, 2017
First Submitted That Met QC Criteria
December 17, 2017
First Posted (ACTUAL)
December 22, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 13, 2018
Last Update Submitted That Met QC Criteria
July 11, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Mental Disorders
- Labor Pain
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Anesthetics, Local
- Ropivacaine
- Sufentanil
Other Study ID Numbers
- TJ-C20171201
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Pain
-
Antalya Bilim UniversityCompletedChildbirth | Normal Labor | Labor Pain and to Reduce PainTurkey (Türkiye)
-
Pınar ErdoğanCompletedLabor Progress | Labor Pain and AnxietyTurkey (Türkiye)
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
Maimonides Medical CenterTerminated
-
Roi TreisterHillel Yaffe Medical CenterNot yet recruitingLabor Pain and to Reduce PainIsrael
-
Istanbul University - CerrahpasaCompletedLabor Pain, Stress, Childbirth SatisfactionTurkey (Türkiye)
Clinical Trials on Ropivacaine Hydrochloride, Sufentanil
-
Peking University First HospitalCompletedEpidural Analgesia | Labor Pain | Dexmedetomidine | Esketamine | Ropivacaine | SufentanilChina
-
Hospices Civils de LyonCompletedPain, PostoperativeFrance
-
Peking University First HospitalCompletedLabor Pain | Analgesia, Obstetrical | Early Medical InterventionChina
-
Maastricht University Medical CenterCompletedAnalgesia, Epidural | Neonatal Outcome | Instrumental Delivery | Maternal OutcomeNetherlands
-
Fudan UniversityShanghai Jiao Tong University School of MedicineCompletedAnesthesia Complications
-
China Medical University, ChinaCompleted
-
First Affiliated Hospital of Jinan UniversityCompletedAnalgesia | Labor Pain | Fetus DisorderChina
-
Poznan University of Medical SciencesRecruiting
-
University of AlbertaWithdrawnLiver Diseases | Bowel Disease | Pancreas Disease | Anesthesia; FunctionalCanada
-
Nanjing Medical UniversityCompleted